The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Rapid Market Expansion

• Current Market Size: Surged from $2.53 billion in 2023 to $2.88 billion in 2024.
• Growth Rate: Compound annual growth rate (CAGR) of 14.0%.
• Key Drivers:
  • Advancements in proteomic research.
  • Drug discovery and development activities.
  • Biotechnology and life sciences research.
  • Rising prevalence of chronic diseases.
  • Increasing adoption of personalized medicine.

Future Market Outlook

• Projected Growth: Expected to reach $4.92 billion by 2028.
• Growth Rate: CAGR of 14.4%.
• Driving Forces:
  • Expanding applications in clinical diagnostics.
  • Growing emphasis on biomarker discovery.
  • Biopharmaceutical production and quality control.
  • Technological integration in research platforms.
  • Rise in proteomic profiling for personalized therapies.

View More On The Protein Assays Market Report 2024 – https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report

Emerging Catalyst: Healthcare Infrastructure Boom

• Healthcare Infrastructure Development: Key driver for future market growth.
• Impact: Enables enhanced diagnosis and treatment.
• Example: OECD reported a 6% growth in health spending across 20 OECD nations in 2021.
• Outcome: Driving demand for protein assays in various diagnostic applications.

Leading Market Players

• Prominent Companies:
  • Pfizer Inc.
  • Johnson & Johnson
  • General Electric Company
  • F. Hoffmann-La Roche AG
  • AstraZeneca PLC
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics International AG
  • Takeda Pharmaceutical Company Limited
  • Danaher Corporation
  • Eli Lilly and Company
  • Many more.

Innovations Propel Market Advancements

• 3D Spatial Analysis Kits: Focus on spatial data analysis.
  • Example: Pixelgen Technologies AB’s ‘Pixelgen Single Cell Spatial Proteomics Kit’.
  • Features: Enhances comprehension of cellular activity.
  • Benefits: Accelerates drug discovery, improves diagnostic capabilities.

Strategic Acquisitions Drive Growth

• Biovision Acquisition by Abcam PLC:
  • Acquisition Date: October 2021.
  • Acquisition Value: USD 340 million.
  • Impact: Strengthens Abcam’s internal innovation and market presence.
  • Outcome: Access to BioVision’s product line and expertise.

Market Segmentation

• By Product Type:
  • Reagents And Kits
  • Instruments
• By Technology Type:
  • Absorbance Based Protein Assays
  • Colorimetric Protein Assays
  • Fluorescence Based Protein Assays
• By End User:
  • Pharmaceutical Industry
  • Biotechnology Industry
  • Clinical Laboratories
  • Hospitals
  • Academic Research Institutes

Regional Insights

• North America: Dominant region in 2023.
• Asia-Pacific: Expected to witness the fastest growth during the forecast period.

The protein assays market is experiencing significant growth driven by technological advancements, increasing healthcare spending, and a focus on personalized medicine. Innovations such as 3D spatial analysis kits and strategic acquisitions are shaping the market landscape, while expanding applications and standardization efforts promise a bright future for this essential segment of the healthcare industry.

Request A Sample Of The Global Protein Assays Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=9173&type=smp